Oral Doxycycline for Acne in a 2026 Systematic Review: Study Design and Evidence Limits for Adults With Persistent Acne

A March 17, 2026 systematic review pooled randomized controlled trials comparing oral doxycycline with other therapies for acne vulgaris. It found doxycycline broadly comparable to azithromycin for improvement, but with important scoring and safety differences and small-sample limits for adults with persistent acne. Acne vulgaris is inflammation of oil glands and hair follicles that causes pimples, tender red bumps, and sometimes scarring. For adults, persistent means moderate-to-severe or treatment-resistant inflammatory acne that has not cleared with topical care.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

How was the 2026 review designed?
What did it find for clearing acne?
How do side effects compare?
Who might consider doxycycline?
How to use it for the shortest effective course?

How was the 2026 review designed?

The review followed PRISMA methods for systematic reviews of trials, according to the U.S. National Library of Medicine's PubMed record.

It combined randomized controlled trials that tested oral doxycycline against other active acne therapies. That design allows direct comparison across studies rather than results from one clinic. It also means the findings reflect the trials included, not a dedicated study of adults with long-lasting acne alone.

What did it find for clearing acne?

Pooled efficacy showed no significant difference between doxycycline and azithromycin, with odds ratio 1.28, according to the National Institutes of Health's full review text. Change in inflammatory lesion counts also did not differ significantly versus controls.

Control treatments improved Global Acne Grading System scores more than doxycycline. In a 3-trial, 406-patient analysis, azithromycin pulse therapy scored 1.81 points better.

How do side effects compare?

Doxycycline causes more gastrointestinal upset and photosensitivity than azithromycin pulse therapy, according to Dermatology Times reporting on the comparison. Photosensitive eruption occurred in about 3% of patients taking 100 mg daily.

Sun protection, food with doses when needed, and prompt reporting of rash, severe nausea, or eye sensitivity matter during use. Readers who burn easily, work outdoors, or have a history of stomach upset should discuss these trade-offs before starting.

Who might consider doxycycline?

Adults affected are those with moderate-to-severe or treatment-resistant inflammatory acne. Guidelines reserve systemic antibiotics for cases not improving with topical retinoids, benzoyl peroxide, or topical antibiotics. Practical checks before asking about an oral antibiotic:.

Acne is mainly red, inflamed bumps or painful lesions, not only blackheads
Topical retinoid, benzoyl peroxide, or topical antibiotic has been tried consistently
Breakouts persist, spread, scar, or impair work, sleep, or mood
Pregnancy, breastfeeding, allergy, or interacting medicines are reviewed with the prescriber

How to use it for the shortest effective course?

Use systemic doxycycline for the shortest needed course, with reassessment at 3 to 4 months and generally not beyond about 6 months. Always pair it with benzoyl peroxide or a retinoid, then continue topical maintenance to reduce resistance.

The FDA labeling defines doxycycline as adjunctive therapy for severe acne, with usual adult dosing of 200 mg on day one as 100 mg every 12 hours, then 100 mg daily. The label allows taking it with food or milk if gastric irritation occurs.